Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Caroline Ferse"'
Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19
Autor:
Abakar Magomedov, Daniel Zickler, Stoyan Karaivanov, Annika Kurreck, Frédéric H. Münch, Julian Kamhieh-Milz, Caroline Ferse, Andreas Kahl, Sophie K. Piper, Kai-Uwe Eckardt, Thomas Dörner, Jan Matthias Kruse
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract COVID 19 is associated with a hypercoagulable state and frequent thromboembolic complications. For how long this acquired abnormality lasts potentially requiring preventive measures, such as anticoagulation remains to be delineated. We used
Externí odkaz:
https://doaj.org/article/885f70bb2e6d41c7a45fd6cabd7e91db
Autor:
Thomas Ihl, Michael Ahmadi, Inga Laumeier, Maureen Steinicke, Caroline Ferse, Philipp Klyscz, Matthias Endres, Sidsel Hastrup, Holger Poppert, Frederick Palm, Farid I. Kandil, Joachim E. Weber, Paul von Weitzel-Mudersbach, Martin L.J. Wimmer, Heinrich J. Audebert
Publikováno v:
Ihl, T, Ahmadi, M, Laumeier, I, Steinicke, M, Ferse, C, Klyscz, P, Endres, M, Hastrup, S, Poppert, H, Palm, F, Kandil, F I, Weber, J E, Von Weitzel-Mudersbach, P, Wimmer, M L J & Audebert, H J 2022, ' Patient-Centered Outcomes in a Randomized Trial Investigating a Multimodal Prevention Program After Transient Ischemic Attack or Minor Stroke : The INSPiRE-TMS Trial ', Stroke, vol. 53, no. 9, pp. 2730-2738 . https://doi.org/10.1161/STROKEAHA.120.037503
Stroke 53(9), 2730-2738 (2022). doi:10.1161/STROKEAHA.120.037503
Stroke 53(9), 2730-2738 (2022). doi:10.1161/STROKEAHA.120.037503
Background:The INSPiRE-TMS trial (Intensified Secondary Prevention Intending a Reduction of Recurrent Events in Transient Ischemic Attack and Minor Stroke Patients) investigated effects of a multicomponent support program in patients with nondisablin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03088ffe6efec514f3a60cbf58eaff20
https://pure.au.dk/portal/da/publications/patientcentered-outcomes-in-a-randomized-trial-investigating-a-multimodal-prevention-program-after-transient-ischemic-attack-or-minor-stroke(ba1952e4-e825-4d36-afe9-543a52bb33fa).html
https://pure.au.dk/portal/da/publications/patientcentered-outcomes-in-a-randomized-trial-investigating-a-multimodal-prevention-program-after-transient-ischemic-attack-or-minor-stroke(ba1952e4-e825-4d36-afe9-543a52bb33fa).html
Autor:
Shufan Huo, Caroline Ferse, Fabian Bösl, S. Momsen Reincke, Philipp Enghard, Carl Hinrichs, Sascha Treskatsch, Stefan Angermair, Kai-Uwe Eckardt, Heinrich J. Audebert, Christoph J. Ploner, Matthias Endres, Harald Prüss, Christiana Franke, Franziska Scheibe
Publikováno v:
Journal of neurology 269(8), 4013-4020 (2022). doi:10.1007/s00415-022-11152-5
Autor:
Moritz L, Schmidbauer, Caroline, Ferse, Farid, Salih, Carsten, Klingner, Rita, Musleh, Stefan, Kunst, Matthias, Wittstock, Bernhard, Neumann, Karl-Michael, Schebesch, Julian, Bösel, Jana, Godau, Piergiorgio, Lochner, Elisabeth H, Adam, Kolja, Jahnke, Benjamin, Knier, Ingo, Schirotzek, Wolfgang, Müllges, Quirin, Notz, Markus, Dengl, Andreas, Güldner, Oezguer A, Onur, Jorge, Garcia Borrega, Konstantinos, Dimitriadis, Albrecht, Günther, On Behalf Of The Ignite Study Group
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 605
Journal of Clinical Medicine, Vol 11, Iss 605, p 605 (2022)
Journal of Clinical Medicine, Vol 11, Iss 605, p 605 (2022)
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) profoundly impacts hemostasis and microvasculature. In the light of the dilemma between thromboembolic and hemorrhagic complications, in the present paper, we systematically in
Autor:
Jorge Garcia Borrega, Jana Godau, Elisabeth H Adam, Oezguer A. Onur, Quirin Notz, Caroline Ferse, Ingo Schirotzek, Kolja Jahnke, Stefan Kunst, Markus Dengl, Rita Musleh, Benjamin Knier, Andreas Güldner, Konstantinos Dimitriadis, Bernhard Neumann, Farid Salih, Moritz L. Schmidbauer, Julian Bösel, Albrecht Günther, Piergiorgio Lochner, Carsten M. Klingner, Matthias Wittstock, Wolfgang Müllges
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) profoundly impacts on hemostasis and microvasculature. Correspondingly, antithrombotic therapy is frequently used for prophylaxis or treatment of thromboembolic complications a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fd5956ee2e1e74428dd53908b49b5b2
https://doi.org/10.21203/rs.3.rs-546639/v1
https://doi.org/10.21203/rs.3.rs-546639/v1
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
Autor:
Heinrich J. Audebert, Mirja Steinbrenner, S. Momsen Reincke, Kai-Uwe Eckardt, Andrea Rocco, Harald Prüß, Elisa Sanchez-Sendin, Jonas A. Hosp, Christoph J. Ploner, Stefan Angermair, Daniel Zickler, Caroline Ferse, Christiana Franke, Jakob Kreye, Matthias Endres, Sascha Treskatsch, Rick Dersch
Publikováno v:
Brain, behavior and immunity 93, 415-419 (2021). doi:10.1016/j.bbi.2020.12.022
Brain, Behavior, and Immunity
Brain, Behavior, and Immunity
Highlights • COVID-19 patients show a broad spectrum of neurological manifestations. • SARS-CoV-2 is scarcely detected in cerebrospinal fluid. • Viral-triggered autoimmune responses may lead to neurological symptoms. • Immunotherapy should be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0def0114ffc2b49ccfe15a4a77dc5559
https://pub.dzne.de/record/155135
https://pub.dzne.de/record/155135
Autor:
Michael Ahmadi, Heinrich J. Audebert, Inga Laumeier, Johannes Wolz, Maureen Steinicke, Caroline Ferse, Georg Michelson
Publikováno v:
International Ophthalmology. 37:39-46
The aim of the study is to telemedically assess the prevalence of simple optic nerve atrophy and retinal arteriolar anomalies in subjects who have had a minor stroke or TIA within 14 days, and to compare these results with an age-matched control grou
Publikováno v:
DNP - Der Neurologe und Psychiater. 16:18-20
Dass die strenge Einstellung des Blutdruckes auf Werte unter 140/85 mmHg in der Sekundarpravention nach Schlaganfall langfristig sinnvoll ist, haben verschiedene Studien belegt [1, 2] und wird in internationalen Leitlinien empfohlen [3, 4]. Doch wie